NPP

  Introduction Rare diseases are, in most cases, serious, chronic, debilitating and life-threatening illnesses, which affects a small portion of people compared to other highly prevalent diseases affecting the general population. Due to this, there are various challenges pertaining to diagnosis and treatment including the involved costs. i   Rare cancers are tumors that occur infrequently in the general population and can develop in people of any age group. ii Understanding the Challenge of Rare Cancer Treatments Due to the lower prevalence of rare cancers, there is shortage of accessible cancer registries and tissue banks, along with limited data published for their diagnosis and treatment, along with limited availability of the necessary clinical skill set to manage the rare diseases. This leads to late or incorrect diagnosis, lower confidence in clinical decision making and possible indifference in developing new drugs. 2 Furthermore, there are challenges with investments...

Rare diseases may affect only a few at a time, but together they  impact  6–8% of the population, with 6000–8000 conditions  identified  globally and around 450 known in India. Many are genetic, often affecting children, yet diagnosis and treatment are delayed because of limited awareness, research gaps,  high costs , and restricted access to quality care. Although the Government of India recognised rare diseases as a priority in 2017 through the National Policy for Rare Diseases, families still face enormous challenges in getting  timely , affordable support. 1 This is where platforms like  Rx4 U  matter. By helping families find verified  assistance  options, navigate documentation, and access available schemes or funding channels,  Rx4 U  reduces confusion and bridge the gap between urgent need and actual access, making an overwhelming journey feel a little less heavy. The Challenge of Accessing Rare Disease Medicines in Ind...